Immunoadjuvant Activity Research Articles

Synthesis and immunoadjuvant activity of 1-.ALPHA.-O-, 1-.BETA.-S- and 6-O-(2-tetradecylhexadecanoyl) derivatives of N-acetylmuramoyl-L-ananyl-D-isoglutamine methyl ester.

Synthesis and immunoadjuvant activity of 1-.ALPHA.-O-, 1-.BETA.-S- and 6-O-(2-tetradecylhexadecanoyl) derivatives of N-acetylmuramoyl-L-ananyl-D-isoglutamine methyl ester.

Catabolic effects of muramyl dipeptide on rabbit chondrocytes

Muramyl dipeptide, an essential structure for the diverse biologic activities of bacterial cell wall peptidoglycan, inhibited the synthesis of glycosaminoglycan/proteoglycan in cultured rabbit costal chondrocytes in a dose-dependent manner. Muramyl dipeptide, as well as lipopolysaccharide and interleukin-1 alpha, also enhanced the release of 35S-sulfate-prelabeled glycosaminoglycan/proteoglycan from the cell layer, which seems to reflect, at least partially, the increasing degradation of glycosaminoglycan/proteoglycan. Five synthetic analogs of muramyl dipeptide known to be adjuvant active or adjuvant inactive were tested for their potential to inhibit synthesis of glycosaminoglycan/proteoglycan and to enhance the release of glycosaminoglycan/proteoglycan in chondrocytes. The structural dependence of these synthetic analogs on chondrocytes was found to parallel that of immunoadjuvant activity. These results suggest that muramyl dipeptide is a potent mediator of catabolism in chondrocytes.

Synthesis and immunoadjuvant activity of N-[2- O-(2-acetamido-1,2,3,5-tetradeoxy-1,5-imino- d-glucitol-3-yl)- d-lactoyl]- l-alanyl- d-isoglutamine

We now describe as part of our continuing research on structure-activity relationships in the MDP series the synthesis and immunoadjuvant activity of N-acetyl-1,5-dideoxy-1,5-imino-muramoyl-L-alanyl-D-isoglutamine

Lysozyme susceptibility of partially deacetylated chitin

Lysozyme susceptibility of partially deacetylated chitins (DACs) was investigated by viscometric and gel permeation chromatographic procedures. The highest lysozyme susceptibility was shown by the DAC of around 70% deacetylation which have already been reported to have the highest immunoadjuvant activity through mouse peritoneal macrophage activation.

ChemInform Abstract: Alternative Synthesis of O‐(2‐Acetamido‐2‐deoxy‐β‐D‐glucopyranosyl)‐(1 → 4)‐N‐acetylnormuramoyl‐L‐α‐aminobutanoyl‐D‐isoglutamine.

AbstractAn alternative synthesis of the known title compound (VIII), an agent exhibiting high immunoadjuvant activity, starts from the benzoylation product (Ib) of the readily available normuramate (Ia).

Synthesis and immunoadjuvant activity of 2,2′- O-[2,2′-diacetamido-2,3,2′,3′-tetradeoxy-6,6′-di- O-(2-tetradecyl-hexadecanoyl)-α, α′-trahalose-3,3′-diyl]bis( N- d-lactoyl- l-alanyl- d-isoglutamine)

The disaccharide of 6- O-(2-tetradecylhexadecanoyl)muramoyl dipeptide coupled through an α-(1↔1)-α linkage, named in the title, and an analog bearing a single peptide moiety, have been synthesized from 2,2′-diazido-2,2′-dideoxy-α,α′-trehalose. The immunoadjuvant activities of the products were examined.

Effect of interleukin-2 on the immunoadjuvant action of liposomes

Effect of interleukin-2 on the immunoadjuvant action of liposomes

Synthesis and Immunoadjuvant Activity of the Conjugates of 1-Thio-N-acetyl-muramoyl Dipeptide with Lipid A Subunit Analogs

A variety of immunomodulators were synthesized by combining biologically active derivatives of 1-thio-muramoyl dipeptide with 4-O-phosphono-d-glucosamine derivatives related to bacterial lipid A, and using the (succinoylamino)undecanoyl group as a spacer. Their immunoadjuvant activities in guinea-pigs were examined.

Immunoadjuvant action of liposomes: comparison with other adjuvants.

Dehydration-rehydration vesicles (DRV liposomes) composed of equimolar phospholipid and cholesterol and containing bovine serum albumin (BSA) were used together with free BSA to immunize Balb/C mice. Primary and secondary immune responses (IgG1) to the liposomal antigen, as measured by ELISA in mouse sera, were similar for egg phosphatidylcholine (PC) and distearoyl phosphatidylcholine (DSPC) DRV, and much greater than those elicited by free BSA. The adjuvanticity of PC DRV was compared with that of aluminium salts (alum), complete Freund's adjuvant (CFA) and N-acetyl muramyl-L-threonyl-D-isoglutamine ([Thr1]MDP), the latter used as such or in a liposome form co-entrapped with the antigen. DRV (with or without co-entrapped [Thr1]MDP), and alum were equally strong in producing primary and secondary immune responses (IgG1) to BSA. Such responses were significantly higher than those achieved with CFA and [Thr1]MDP alone. The implications of these results for the potential role of liposomes as immunological adjuvants in vaccines are discussed.

Synthesis and biological activity of 6-O-(3-acyloxytetradecanoyl)-N-acetyl-muramoyl dipeptide methyl ester and related compounds.

A variety of 6–O-(3-acyloxytetradecanoyl)-MDP methyl esters were synthesized using optically-active (3/?)-3-acyloxytetradecanoic acid. Their immunoadjuvant activity was examined.

Synthesis and immunoadjuvant activity of the conjugates of 1-thio-N-acetyl-muramoyl dipeptide with lipid A subunit analogs.

A variety of immunomodulators were synthesized by combining biologically active derivatives of 1-thio-muramoyl dipeptide with 4-O-phosphono-d-glucosamine derivatives related to bacterial lipid A, and using the (succinoylamino)undecanoyl group as a spacer. Their immunoadjuvant activities in guinea-pigs were examined.

Synthesis and immunoadjuvant activity of N-acetyl-6-O-phosphonomuramoyl-L-alanyl-D-isoglutamine methyl ester and its lipophilic derivatives.

N-Acetyl-6-O-phosphono-muramoyl-l-alanyl-d-isoglutamine methyl ester and a variety of its 1-α-O-acyl derivatives were synthesized from benzyl 2-acetamido-2-deoxy-3-O-[d-1-(methoxycar-bonyl)ethyl]-β-d-glucopyranoside. Their immunoadjuvant activity in guinea-pigs was examined.

Modulation of interferon-γ-induced major histocompatibility (MHC) and CD14 antigen changes by lipophilic muramyltripeptide MTP-PE in human monocytes

The lipophilic muramylpeptide derivative muramyltripeptide-phosphatidylethanolamine (MTP-PE, 0.05 to 5 μg/ml) and human recombinant interferon-γ (rIFN-γ, 1 to 100 U/ml) were applied singly or in combination to fresh human mononuclear blood leucocytes in vitro. After 15 to 72 hr incubation, culture- and drug-induced changes in β2-microglobulin (MHC class I associated), HLA-DR (MHC class II), and Leu-M3 (CD14) antigen expression were investigated by flow cytometry; changes in monocyte morphology (forward light scatter and side scatter) were assessed by scatter analysis. It was found that (1) rIFN-γ caused a simultaneous down-regulation of the CD14 antigen and an up-regulation of MHC class I and class II molecules on the surface of cultured monocytes; (2) MTP-PE, which by itself failed to influence the expression of these antigens, synergized with rIFN-γ in increasing MHC antigens and reducing CD14; (3) at high concentrations rIFN-γ reduced monocyte viability to a small but significant extent and this effect was further potentiated by MTP-PE; and (4) untreated monocytes in culture showed an apparently MTP-PE-insensitive increase in size, density, and β2-microglobulin, HLA-DR, and CD14 antigen expression. The influence of MTP-PE on rIFN-γ-induced surface marker changes may contribute to its immunoadjuvant activity in vivo.

Immunobiological activities of a porin fraction isolated from Fusobacterium nucleatum ATCC 10953.

From Fusobacterium nucleatum ATCC 10953 cell envelope fraction whose inner membranes had been removed by treatment with sodium N-lauroyl sarcosinate, an outer membrane protein (37,000 Mr in a native state) was prepared by extraction with lithium dodecyl sulfate. The protein thus obtained showed distinct porin activity, namely, the ability to form hydrophilic diffusion pores by incorporation into the artificial liposome membrane. The porin fraction exhibited strong immunobiological activities in the in vitro assays: B-cell mitogenicity and polyclonal B-cell activation on murine splenocytes, stimulatory effects on guinea pig peritoneal macrophages, and enhancement of the migration of human blood monocytes. The porin fraction also exhibited immunoadjuvant activity to increase the antibody production against sheep erythrocytes in the spleen of mice that were immunized by sheep erythrocytes with porin. Although chemical analyses revealed that the test porin fraction contained a considerable amount of lipopolysaccharide (LPS) (around 12% of the fraction), the studies with LPS-nonresponding C3H/HeJ mice and on the inhibitory effects of polymyxin B strongly suggest that most of the above bioactivities are due to porin protein itself, not to coexistent LPS in the porin fraction.

Synthesis of the Polymer of 1 {3-O[(R)-1 (L-Alanyl-D-Isoglutamyl Carbonyl) Ethyl]-α-D-Glucopyranos-6-O-Carbonycarbonyl}Ethylene

Abstract The polymer of 1- 3-O [(R)1-(L-alanyl-D-isoglutamyl carbonyl)ethyl] α-D-glucopyranos-6-O-carbonyl ethylene was synthesized as a acryloyl type polymer by fixing the D-glucose analog (GADP) of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP), which is the minimum required structure responsible for the immunoadjuvant activity of bacterial cell-wall peptidoglycan. N- [2-(1,2-O-Isopropylidene-6-O-acryloyl-α-D-glucofuranos-3-Oyl)-(R)-propionyl] -L-alanyl-D-isoglutamine benzyl ester (6) was prepared as a key monomer in the synthesis. The homopolymerization of 6 and the copolymerization of 6 with hydrophobic acryloyl monomers were carried out in benzene at 60°C by using 2,2′-azobisisobutyronitrile as a radical initiator to give homopolymer 7 and copolymer 10, respectively. Removal of isopropylidene and benzyl protecting groups from 7, 10 and 8, 11 was carried out by acid treatment with trifluoroacetic acid/water (6:1 v/v) and by catalytic hydrogenolysis with palladium carbon, respectively, to afford the hom...

Possible Existence of a Novel Amphipathic Immunostimulator in the Phenol‐Water Extracts of Mycobacteriaceae

The extracts having diverse immunostimulating activities were obtained as a water-phase fraction from four bacterial species representing the 4 genera (Mycobacterium, Nocardia, Gordona, and Rhodococcus) of Mycobacteriaceae by the phenol-water method, which is commonly used for extraction of endotoxic lipopolysaccharides (LPS) from gram-negative bacteria and amphipathic substances from gram-positives. These fractions, especially those of G. aurantiaca and R. terrae, showed strong stimulatory effects on murine splenocytes, macrophages of mice and guinea pigs, the immunoadjuvant activities in guinea pigs and mice, and the distinct activities inducing a tumor necrosis factor and interferons alpha/beta and gamma in primed mice. The fractions from G. aurantiaca and R. terrae exhibited potent pyrogenicity and the ability to activate the clotting enzyme cascade of the horseshoe crab (Tachypleus tridentatus). Some of these biological activities were not very different from the potency of the reference endotoxic LPS derived from Escherichia coli or Fusobacterium nucleatum. But the test fractions neither showed the activity to prepare rabbit skin to the local Shwartzman reaction, nor reacted with anti-lipid A conventional and monoclonal antibodies. Furthermore, unlike LPS, these fractions stimulated the splenocytes of C3H/HeJ mice (LPS-Nonresponder). Although the fractions showing the above biological activities have not yet been adequately purified, they contained polysaccharides, whose main constituent sugar is mannose with a smaller amount of arabinose, fatty acids consisting primarily of palmitic, stearic, and tuberculostearic acids, and small amounts of peptides and amino sugars. Since components characteristic of known immunomodulators of bacterial origin, namely endotoxins (lipid A's), cell wall peptidoglycans, lipoteichoic acids, cord factors (trehalose dimycolates), or deoxyribonucleic acids, were practically not detected in these fractions, the agent responsible for the above bioactivities is considered to be a novel substance different from the known, bacterial immunomodulators.

Synthesis of conjugates between luteinizing hormone releasing hormone (LH-RH) and N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP) models of totally synthetic vaccines.

Two glycopeptides associating the aminoacid sequence of LH-RH with MDP were prepared, using a Lys residue as a linker. These conjugates, N alpha MDP N epsilon (LH-RH)-Lys and N alpha MDP N epsilon (LH-RH)-Lys-NH2 obtained by condensation of fragments were synthesized by liquid as well as solid phase methods. Both compounds were able to induce anti LH-RH antibodies and immunological castration. They retained the immuno-adjuvant activity of MDP. Such antigen-adjuvant constructs, devoid of carrier and obtained by chemically defined and reproducible synthetic methods could offer suitable tools for structure-activity relationship studies aiming at defining synthetic vaccines.

Synthesis of peptide and glycopeptide fragments of bacterial cell walls

Peptides, ranging from tetrapeptide I, II to octadecapeptide XXI and from N-acetylmuramyl-hexapeptide XXIII to tris(N-acetylmuramyl)-octadecapeptide XXVII, were prepared using synthesis in solution as well as solid-phase synthesis. H-L-Ala-D-iGln-L-Lys-D-Ala-(L-Ala)2-OMe (VIII) and its lysine-acetylated analogue X were pyrogenic and the former (VIII) exhibited weak immunoadjuvant activity. The immunoadjuvant activity of tris(N-acetylmuramyl)-octadecapeptide XXVII was comparable with that of MDP and the compound was not pyrogenic.

Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.

Several synthetic acylated glucosamine monophosphates, with structures corresponding to the nonreducing or reducing moiety of the lipid A of the Escherichia coli or Salmonella minnesota type, and a synthetic compound corresponding to a biosynthetic disaccharide lipid A precursor (designated Ia or IVA) were examined for their endotoxic and related bioactivities in comparison with those of the synthetic and bacterial parent molecules, i.e., acylated beta(1-6)-D-glucosamine disaccharide bisphosphates. Some of the test monosaccharide compounds were definitely active in most of the in vitro assays. Their activities, except for complement activation, however, were weaker than those of the reference compounds, synthetic and bacterial acylated disaccharide bisphosphates. The differences between the test monosaccharide and disaccharide compounds were much more apparent in in vivo assays, in which the test acylated glucosamine monophosphates were scarcely active, though some test compounds exhibited weak lethal toxicity in galactosamine-loaded mice and were weakly active in pyrogenicity, immunoadjuvant activity, and possible tumor necrosis factor and alpha and beta interferon-inducing ability in Mycobacterium bovis BCG- and Propionibacterium acnes-primed mice, respectively. Mixture at an equimolar ratio of acyl glucosamine monophosphates, each of which has the structure of the reducing or nonreducing moiety of the reference disaccharide compound, did not restore the endotoxic or associated bioactivities of the corresponding parent molecules. No essential differences in bioactivity were noted between synthetic and bacterial monosaccharide compounds, i.e., lipid X, whose structure corresponds to the reducing moiety of E. coli-type lipid A.

Immunobiological activities of synthetic lipid A analogs with low endotoxicity

Synthetic lipid A analogs, beta(1-6)glucosamine disaccharide 1,4'-bisphosphates, which possesses four tetradecanoyl groups at the 2- and 2'-amino, and 3- and 3'-hydroxyl groups (LA-17-PP), and each two of the (R)-3-hydroxytetradecanoyl and tetradecanoyl groups at the 2- and 2'-amino and 3- and 3'-hydroxyl groups, respectively (LA-18-PP), were far less endotoxic than synthetic (506, LA-15-PP) and bacterial Escherichia coli type lipid A's; neither compound showed any detectable lethal toxicity in chicken embryos or preparatory activity for the local Shwartzman reaction in rabbits. Also both compounds were only weakly pyrogenic and comparably less lethally toxic in galactosamine-loaded mice than the reference synthetic and bacterial lipid A's and a synthetic counterpart to biosynthetic lipid A precursor Ia (406, LA-14-PP). Nevertheless, LA-17-PP and LA-18-PP exhibited definite in vivo immunoadjuvant activity in mice, and the ability to induce a possible tumor necrosis factor and alpha/beta interferon in Mycobacterium bovis BCG and Propionibacterium acnes-primed mice, respectively, although these activities were weaker than those of the reference lipid A's. 4'-Monophosphate analogs of the above two test compounds exhibited neither endotoxic nor beneficial activities, but they showed remarkable in vitro bioactivities comparable to those of the corresponding bisphosphate compounds; the ability to activate the human complement system and the clotting enzyme cascade of horseshoe crab amoebocyte lysate, stimulatory effects on guinea pig and murine peritoneal macrophages, and murine splenocytes.